Isomorphic Labs, an Alphabet spinout, has secured $600 million to enhance its AI drug design platform utilizing advanced machine learning techniques. This funding supports research and team expansion, aiming to revolutionize drug discovery. The initiative has significant implications for healthcare and pharmaceutical industries globally.
💰 Alphabet’s Isomorphic Labs Raises $600M for AI Drug Design Engine
